Excelsior Biopharma Inc.

President and CEO: Mr. Joseph Chen
Established In: 1986
Tel: 886-2-2655-7568
Fax: 886-2-2655-7915
Address: 14F-6, No. 3, Park St., Nangang District, Taipei 11503. Taiwan
          Website: http://www.excelsiorgroup.com.tw


Excelsior Biopharma Inc. and Excelsior Pharmatech Labs.

A Journey of History

Excelsior Biopharma Inc. was founded in 1986. Its primarily role was to import mainly pharmaceutical products and acted as marketing agent. In the early stage, it procured specialty prescription drugs of growing market potential. This was to establish the foundations and prepare for further business development. 

We established our own sales team, which included biotechnological experts, was built to provide professional medical service to all customers. The business management philosophy is founded on our vision of “Professionalism, innovation, excellence and service” until now.

November 1996, Excelsior Pharmatech Labs was founded in the Incubation Center of Industrial Technology Research Institute. It comprised R&D Center, Quality laboratory and pilot plant were set up to develop pharmaceuticals, new Chinese herbal medicines, and new dosage forms. It corporates with national and international pharmaceutical plants to co-develop new drugs with technology transfer. The fruits of the research were abundant and successful. The production was through well-known certificated toll manufacturer in Taiwan to provide high-quality new pharmaceutical products in Taiwan.

Due to the difficulty of sourcing Orphan Drugs and antidotes then in Taiwan, patients who had rare disorders or were exposed to poisons were facing life threatening situations. Excelsior aggressively sourced the orphan drugs from overseas, applied for market authorizations in order to provide treatment readily to rare disease patients. Furthermore, we also aggressively developed and supplied antidotes. Together with Taiwan Poison Prevention Center, we establish the distribution network for emergency medical care. In close collaboration with TPPC we held education symposiums and training programs to strengthen the knowledge of acute poisoning managements.

Cooperated with Chiron Vaccines to import, wholesale, and retail the most advanced influenza vaccines with purified surface antigen.

Seven monoclonal antibody rapid tests were imported and we started diagnostics business for major diseases.

Excelsior Pharmatech Labs. moved to Hsinchu Biomedical Science Park to set up research center for specialty medicines and standard PIC/S GMP plant. Medical laboratory was set up to develop methods of gene analysis and biomarker detection.

Looking into the future development of biotechnology industry, we expected not only to build on professional and integrated technology platforms, but also to work with talents both locally and internationally. With the single mindedness that in the near future Taiwan will excel as one of the major leaders of biotechnology in the world.